y 27632 has been researched along with s-nitroso-n-acetylpenicillamine in 1 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (s-nitroso-n-acetylpenicillamine) | Trials (s-nitroso-n-acetylpenicillamine) | Recent Studies (post-2010) (s-nitroso-n-acetylpenicillamine) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 1,412 | 0 | 230 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hunter, JC; Javadov, S; Karmazyn, M; Kilić, A; Rajapurohitam, V; Zeidan, A | 1 |
1 other study(ies) available for y 27632 and s-nitroso-n-acetylpenicillamine
Article | Year |
---|---|
Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway.
Topics: Actins; Amides; Animals; Animals, Newborn; Cardiomegaly; Cofilin 2; Cyclic GMP; Endothelin-1; Isoenzymes; Models, Biological; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Phosphorylation; Protein Transport; Pyridines; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Time Factors; Transcription Factors | 2009 |